Biomedical Engineering Reference
In-Depth Information
Perumal P, Mekala S, Chaffin WL (2007) Role for cell density in antifungal drug resistance in
Candida albicans biofilms. Antimicrob Agents Chemother 51(7):2454-2463
Pfaller MA, Diekema DJ (2007) Epidemiology of invasive candidiasis: a persistent public health
problem. Clin Microbiol Rev 20(1):133-163
Pierce CG, Uppuluri P, Tristan AR, Wormley FL Jr, Mowat E, Ramage G, Lopez-Ribot JL (2008)
A simple and reproducible 96-well plate-based method for the formation of fungal biofilms and
its application to antifungal susceptibility testing. Nat Protoc 3(9):1494-1500
Pierce CG, Saville SP, Lopez-Ribot JL (2011) Characterization of small molecule inhibitors of
Candida albicans biofilm formation using phenotype-based high content screening: implica-
tions for antifungal drug development. Paper presented at FEBS Advanced Lecture Course on
Human Fungal Pathogens, Le Colle-sur-Loup, France
Pini G, Faggi E, Donato R, Fanci R (2005) Isolation of Trichosporon in a hematology ward.
Mycoses 48(1):45-49
Pitangui NS, Sardi JC, Silva JF, Benaducci T, Moraes da Silva RA, Rodriguez-Arellanes G,
Taylor ML, Mendes-Giannini MJ, Fusco-Almeida AM (2012) Adhesion of Histoplasma
capsulatum to pneumocytes and biofilm formation on an abiotic surface. Biofouling 28(7):
711-718
Pusateri CR, Monaco EA, Edgerton M (2009) Sensitivity of Candida albicans biofilm cells grown
on denture acrylic to antifungal proteins and chlorhexidine. Arch Oral Biol 54(6):588-594
Raad I (1998) Intravascular-catheter-related infections. Lancet 351(9106):893-898
Ramage G, Vande Walle K, Wickes BL, Lopez-Ribot JL (2001a) Standardized method for in vitro
antifungal susceptibility testing of Candida albicans biofilms. Antimicrob Agents Chemother
45(9):2475-2479
Ramage G, Vandewalle K, Wickes BL, Lopez-Ribot JL (2001b) Characteristics of biofilm
formation by Candida albicans. Rev Iberoam Micol 18(4):163-170
Ramage G, Bachmann S, Patterson TF, Wickes BL, Lopez-Ribot JL (2002a) Investigation of
multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms.
J Antimicrob Chemother 49(6):973-980
Ramage G, Saville SP, Wickes BL, Lopez-Ribot JL (2002b) Inhibition of Candida albicans biofilm
formation by farnesol, a quorum-sensing molecule. Appl Environ Microbiol 68(11):
5459-5463
Ramage G, VandeWalle K, Bachmann SP, Wickes BL, Lopez-Ribot JL (2002c) In vitro pharma-
codynamic properties of three antifungal agents against preformed Candida albicans biofilms
determined by time-kill studies. Antimicrob Agents Chemother 46(11):3634-3636
Ramage G, VandeWalle K, Lopez-Ribot JL, Wickes BL (2002d) The filamentation pathway
controlled by the Efg1 regulator protein is required for normal biofilm formation and devel-
opment in Candida albicans. FEMS Microbiol Lett 214(1):95-100
Ramage G, Tomsett K, Wickes BL, Lopez-Ribot JL, Redding SW (2004) Denture stomatitis: a
role for Candida biofilms. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98(1):53-59
Ramage G, Saville SP, Thomas DP, Lopez-Ribot JL (2005) Candida biofilms: an update.
Eukaryot Cell 4(4):633-638
Ramage G, Martinez JP, Lopez-Ribot JL (2006) Candida biofilms on implanted biomaterials: a
clinically significant problem. FEMS Yeast Res 6(7):979-986
Ramage G, Mowat E, Jones B, Williams C, Lopez-Ribot J (2009) Our current understanding of
fungal biofilms. Crit Rev Microbiol 35(4):340-355
Ramage G, Rajendran R, Sherry L, Williams C (2012) Fungal biofilm resistance. Int J Microbiol
2012:528521
Ravi S, Pierce C, Witt C, Wormley FL Jr (2009) Biofilm formation by Cryptococcus neoformans
under distinct environmental conditions. Mycopathologia 167(6):307-314
Redding S, Bhatt B, Rawls HR, Siegel G, Scott K, Lopez-Ribot J (2009) Inhibition of Candida
albicans biofilm formation on denture material. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 107(5):669-672
Search WWH ::
Custom Search